Analysis on the application and prognosis of intraoperative blood salvage in infective endocarditis / 国际外科学杂志

Objective:To explore the effect of intraoperative blood salvage (IBS) in the operation of infective endocarditis (IE) and the risk factors of death within half a year after operation.Methods:Used retrospective research methods, a total of 61 patients who were diagnosed as IE and received surgical treatment in Department of Cardiovascular and Large Vascular Surgery, Huizhou Central People′s Hospital from April 2017 to November 2020 were selected as subjects. The patients were divided into autologous group ( n=30) and allogeneic group ( n=31) according to different blood transfusion methods. Patients in the autogenous group received IBS, and patients in the allogeneic group received allogeneic blood transfusion. The indexes of coagulation function [activated partial thromboplastin time(APTT), thrombin tim(TT), prothrombin time(PT), D-dimmer(D-D), fibrinogen degradation product(FDP)], immune reaction (CD3 + CD4 + T cells, CD3 + CD8 + T cells, CD16 + CD56 + NK cells, TLR2 + cells, TLR4 + cells) and inflammatory reaction [soluble CD40 ligand(sCD40L), neutrophil chemokine -1(CINC-1), tumor necrosis factor-α(TNF-α), interleukin-6(IL-6)] were compared between the autologous group and the allogeneic group, as well as the incidence of postoperative adverse reactions. The end event was death half a year after operation, and the subjects were divided into death group ( n=15) and survival group ( n=46). The clinical data of the death group and the survival group were compared. Measurement data were expressed as mean ± standard deviation ( ± s), and t-test was used for comparison between groups; Chi-square test was used for comparison of enumeration data between groups, and the IBS variables were included and excluded to establish the prediction models of death half a year after operation, respectively. The model was evaluated by the receiver operating characteristic curve (ROC), and the model was internally verified by the method of Bootstrap repeated sampling. IBS was included and removed to establish the prediction model of death within half a year after surgery, and ROC was used to evaluate the model. Bootstrap repeated sampling was used to verify the model internally. Results:Cardiac insufficiency, hypotension, IBS, multivalvular disease and age were independent risk factors for postoperative death ( P<0.05). The model with IBS variables has higher predictive value. 5 days after operation, there were significant differences in the indexes of immune reaction [CD3 + CD4 + T cells: (37.49±5.74)% vs (31.68±4.46)%, CD3 + CD8 + T cells: (23.07±3.24)% vs (17.82±2.29)%, CD16 + CD56 + NK cells: (1.61±0.18)% vs (1.02±0.15)%, TLR2 + cells: (9.24±1.15)% vs (18.40±2.21)%, TLR4 + cells: (7.79±0.82)% vs (12.33±1.57)%] and inflammatory reaction [sCD40L: (59.21±7.80) pg/mL vs (84.33±9.35) pg/mL, CINC-1: (40.27±5.83) pg/mL vs (72.86±9.35) pg/mL, TNF-α: (10.86±1.26) ng/mL vs (17.03±2.20) ng/mL and IL-6: (6.32±0.77) ng/mL vs (11.35±1.74) ng/mL] between autologous group and allogeneic group ( P<0.01). Intra-group comparison of patients in autologous group, before and 5 days after operation, there were significant differences in the indexes of immune response [CD3 + CD4 + T cells: (48.55±6.67)% vs (37.49±5.74)%, CD3 + CD8 + T cells: (30.38±4.69)% vs (23.07±3.24)%, CD16 + CD56 + NK cells: (2.53±0.44)% vs (1.61±0.18)%, TLR2 + cells: (6.50±0.61)% vs (9.24±1.15)%, TLR4 + cells: (4.02±0.63)% vs (7.79±0.82)%] and inflammatory response [sCD40L: (38.64±6.75) pg/mL vs (59.21±7.80) pg/mL, CINC-1: (31.65±5.68) pg/mL vs (40.27±5.83) pg/mL, TNF-α: (7.59±0.85) ng/mL vs (10.86±1.26) ng/mL and IL-6 (5.10±0.63) ng/mL vs (6.32±0.77) ng/mL] ( P<0.01). Intra-group comparison of patients in allogeneic group, before and 5 days after operation, there were significant differences in the indexes of immune reaction [CD3 + CD4 + T cells: (49.13±6.82)% vs (31.68±4.46)%, CD3 + CD8 + T cells: (30.65±4.91)% vs (17.82±2.29)%, CD16 + CD56 + NK cells: (2.51±0.26)% vs (1.02±0.15)%, TLR2 + cells: (6.36±0.66)% vs (18.40±2.21)%, TLR4 + cells (4.08±0.56)% vs (12.33±1.57)%] and inflammatory response [sCD40L: (39.14±6.03) pg/mL vs (84.33±9.35) pg/mL, CINC-1: (31.24±5.77) pg/mL vs (72.86±9.35) pg/mL, TNF-α: (7.64±0.76) ng/mL vs (17.03±2.20) ng/mL and IL-6: (5.04±0.82) ng/mL vs (11.3±1.74) ng/mL] ( P<0.01). There were 3 cases of hypoproteinemia, 2 cases of incision infection and 1 case of cardiac adverse event in the autologous group; 4 cases of hypoproteinemia, 3 cases of incision infection and 1 case of cardiac adverse event in the allogeneic group. There was no significant difference in the incidence of postoperative adverse reactions between the two groups ( P>0.05). Conclusions:The predictive model included in IBS can better predict the mortality of within half a year after IE. The use of IBS in IE surgery will not significantly affect the blood coagulation function and the incidence of postoperative adverse reactions, but can improve immune function and inhibit inflammatory reaction.

Effects of intraoperative blood salvage on red blood cells / 中国输血杂志

Intraoperative blood salvage (IBS) is a life support technology that uses a series of artificial devices to treat the recycled blood during surgery, which then is transfused back into the patients. Currently, it′s the key method for perioperative blood protection. With the continuous development of science and technology as well as the deepening of researches, it has been realized that the damage of autologous blood recycling to red blood cells can not be ignored. This paper reviews the current progress of IBS researches and their effects on RBC.

Autologous blood salvage in cardiac surgery: clinical evaluation, efficacy and levels of residual heparin

ABSTRACT Objective: Intraoperative blood salvage (cell saver technique) in cardiac surgery is universally used in surgical procedures with a marked risk of blood loss. The primary objectives of this study were to determine the concentration of residual heparin in the final product that is reinfused into the patient in the operating room and to evaluate the efficacy and safety of the cell saver technique. Method: Twelve patients undergoing elective cardiac surgery were enrolled in this study. Using the XTRA Autotransfusion System, blood samples were collected from the cardiotomy reservoir, both prior to blood processing (pre-sample) and after it, directly from the bag with processed product (post-sample). Hematocrit and hemoglobin levels, the protein, albumin and residual heparin concentrations, hemolysis index, and the platelet, erythrocyte and leukocyte counts were measured. Results: Hematocrit and hemoglobin levels and red blood cell counts were higher in post-processing samples, with a mean variation of 54.78%, 19.81 g/dl and 6.84 × 106/mm3, respectively (p < 0.001). The mean hematocrit of the processed bag was 63.49 g/dl (range: 57.2-67.5). The residual heparin levels were ≤0.1 IU/ml in all post-treatment analyses (p = 0.003). No related adverse events were observed. Conclusion: The reduced residual heparin values (≤0.1 IU/ml) in processed blood found in this study are extremely important, as they are consistent with the American Association of Blood Banks guidelines, which establish target values below 0.5 IU/ml. The procedure was effective, safe and compliant with legal requirements and the available international literature.

Patient Blood Management: Anesthesiologist's Perspectives / 한양의대학술지

Preoperative anemia should be diagnosed and treated before surgery, because anemia is associated with increased postoperative mortality and morbidity. Even if iron deficiency is not detected, the possibility of functional iron deficiency should be considered. During surgery, patients should be managed to avoid hypothermia, acidosis, and hypocalcemia, while maintaining adequate blood pressure and preventing dilutional coagulopathy. It is currently recommended to start transfusion when hemoglobin is under 7–8 g/dL in patients without cardiac problems, using restrictive strategy rather than liberal, due to dangers of complications from transfusion. For those who refuse transfusion, or when transfusion is difficult due to multiple antibodies, or when attempting to reduce allogeneic transfusion, preoperative autologous blood donation (PAD), intraoperative acute normovolemic hemodilution (ANH), intraoperative blood salvage, or postoperative blood salvage can be used. For patients with trauma or massive bleeding, damage control resuscitation of permissive hypotension, restriction of crystalloid infusion, transfusion of blood product in a ratio similar to whole blood (1:1:1 of FFP, platelets, PRBC) must be actively carried out.

A study on the quality of the processed blood salvaged during brain surgery / 中国输血杂志

90%, respectively. Although some shape changed red blood cells were observed in the washed blood, discocytes were the dominant form, with the percentage of discocytes being (58.0 ? 8.0)%. A greater number of shape-changed red blood cells were found in 2-week-old banked RBCs (P

Intraoperative Blood Salvage and Transfusion During Spinal Surgery / 대한마취과학회지

25 Patients were received major spinal surgeries at main operating theater of Kangnam General Hospital from May 1990 to December 1990 by using the Haemonetics cell saver which was employed as an intraoperative blood salvage and autologous blood transfuser. The products of washed red blood cells were an average of 1490 cc packed RBC per case. Under the Light Microscopy, Washed RBC disclosed the morphologies of normal RBC size and shape. Fragmented RBCs or cell debris were not found and in one case agglutinated and denaturated RBCs were seen. While 20 patients were received spinal surgery prior to the utilization of cell saver, an average of 7.85 units of banked whole blood was transfused compared with 5.55 units in the cases of using the cell saver (p<0.05). Homologous banked blood utilization during spinal surgery declined more than 30% with the use of the cell saver. There was no evidence of infection, renal and/or hepatic failure related to the use of the cell saver. Haemonetics cell saver appeared to be safe, efficient and more over in some instanes life saving.

Application of Intraoperative Autologous Blood Salvage on Radical Nephrectomy for Renal Carcinoma with Inferior Vena Cava Tumor Thrombus / 医疗卫生装备

Objective To evaluate the application and risk of hematogenous tumor dissemination of intraoperative autologous blood salvage on radical nephrectomy for renal carcinoma with inferior vena cava tumor thrombus.Methods Between July 1999 and October 2005,19 patients with renal cell carcinoma invading inferior vena cava were used by the intraoperative autologous blood salvage.Preoperative and postoperative clinical data were analyzed and compared.The blood sparing effect and follow-up were evaluated.Results The intraoperative autologous blood salvage of all cases was successful.The levels of HCT,Hb and RBC on the 1st and 7th postoperative day were significantly lower than preoperative day.Although the level of PLT decreased on the 1st postoperative day,it recovered on the 7th day.The markers of liver and renal function did not change during treat time.Packed red blood cells were collected during surgery with a mean value of 1 765 ml(300～6 000 ml) per patient.The average amount of allogenic transfusion per patient was 2 247ml(0～8000 ml).The perioperative mortality rate was 10.5%(2/19).The postoperative metastasis rate was 35.3%(6/17).No difference was found in the prognosis between two groups.Conclusion The intraoperative autologous blood salvage does not markedly change the clinic test data and not increase the recurrence and metastasis of renal cell carcinoma.